Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 22.61 | -32.73 |
| PEG Ratio (TTM) | 0.23 | -2.63 |
| P/S Ratio (TTM) | N/A | 35.20 |
| P/B Ratio (TTM) | 0.89 | 6.92 |
| P/FCF Ratio (TTM) | -929.62 | -188.63 |
| Price to 5YR AVG Earnings Ratio | N/A | -29.45 |
| Price to 5YR AVG FCF Ratio | -2.48 | -26.95 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.18% | 47.28% |
| ROE (TTM) | 2.93% | -531.53% |
| Net Profit Margin (TTM) | N/A | -265.23% |
| ROIC 5YR AVG | -0.18% | 831.70% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 706.36% | -1.16% | 2,000.24% |
| Revenue | -4.42% | -33.33% | -40.00% |
| Net Income | 729.05% | -24,420.18% | -14,537.00% |
| Cash Flow | -2,172.07% | 180,572,970.87% | 108,343,767.76% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.06 | 4.81 |
| Quick Ratio (TTM) | 0.06 | 24.14 |
| D/E Ratio (TTM) | 0.10 | 0.22 |
| Interest Coverage (TTM) | -5.97 | 2.73 |
| Piotroski F-Score | 3 | 3 |
| Altman Z-Score | 2.76 | 21.22 |
| LTL to 5YR AVG FCF | -8.18 | -1.27 |
| Shares Outstanding Growth 5YR AVG | 1,120.97% | 515.59% |